There have been no studies of parathyroid hormone in children with OI; there is a “black box” warning against the use of parathyroid hormone and parathyroid hormone-related peptide in children, based on the occurrence of osteosarcomas in growing rats receiving these interventions. This evidence concerns the gene PTH and osteosarcoma.